NIH-funded research Sbir 2 grant

Monitoring drug cravings in patients with opioid use disorder using brain responses

Official title: Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials

Funded at Neurotype INC. · NIH-10787065 · Data updated 2026-11-12

This study is testing a new device that uses brainwave technology to help people with opioid use disorder understand their cravings when they see things that remind them of opioids, so they can get better support and reduce the chance of relapse.

More Opioid Use research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionNeurotype INC.
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 30, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$328,963
NIH project number1R44DA059517-01
Project IDNIH-10787065 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with opioid use disorder who are seeking treatment.

Less likely to help

Patients who do not have opioid use disorder or are not seeking treatment for substance use issues may not benefit from this research.

What this research studies

This research aims to develop a device that can objectively monitor cravings for opioids triggered by environmental cues in patients with opioid use disorder (OUD). By using electroencephalogram (EEG) technology, the study will measure brain responses to opioid-related cues and compare them to responses elicited by food cues. The goal is to create a tool that can help predict relapse and improve treatment outcomes for individuals struggling with OUD. The research will involve clinical trials to evaluate the effectiveness of this monitoring approach.

Why it matters

Potential benefit: If successful, this research could provide a new way to predict and manage cravings in patients with opioid use disorder, potentially reducing relapse rates.

How similar studies have gone: Other research has shown promise in using EEG and similar neurophysiological measures to assess cravings and predict relapse in substance use disorders.

Where this research is happening

  • Neurotype INC.
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Burwell, Scott — Neurotype INC.
  • Study coordinator: Burwell, Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.